University of Washington, Seattle, WA 98195, USA.
Arterioscler Thromb Vasc Biol. 2010 Feb;30(2):321-6. doi: 10.1161/ATVBAHA.109.196576. Epub 2009 Nov 30.
Vascular calcification is highly correlated with morbidity and mortality, and it is often associated with inflammation. Vitamin D may regulate vascular calcification and has been associated with cardiovascular survival benefits.
We developed a macrophage/smooth muscle cell (SMC) coculture system and examined the effects of vitamin D receptor activators (VDRA), calcitriol and paricalcitol, on SMC matrix calcification. We found that treatment of SMC alone with VDRA had little effect on phosphate-induced SMC calcification in vitro. However, coculture with macrophages promoted SMC calcification, and this was strikingly inhibited by VDRA treatment. Several VDRA-induced genes, including bone morphogenetic protein-2 (BMP2), tumor necrosis factor-alpha, and osteopontin, were identified as candidate paracrine factors for the protective effect of VDRA. Of these, osteopontin was further investigated and found to contribute significantly to the inhibitory actions of VDRA on calcification in macrophage/SMC cocultures.
The ability of VDRA to direct a switch in the paracrine phenotype of macrophages from procalcific to anticalcific may contribute to their observed cardiovascular survival benefits.
血管钙化与发病率和死亡率高度相关,且常与炎症相关。维生素 D 可能调节血管钙化,并与心血管生存获益相关。
我们建立了一个巨噬细胞/平滑肌细胞(SMC)共培养体系,并研究了维生素 D 受体激动剂(VDRA)、骨化三醇和帕立骨化醇对 SMC 基质钙化的影响。我们发现,VDRA 单独处理 SMC 对体外磷酸盐诱导的 SMC 钙化作用很小。然而,与巨噬细胞共培养促进了 SMC 钙化,而 VDRA 处理则显著抑制了这种钙化。几种 VDRA 诱导的基因,包括骨形态发生蛋白 2(BMP2)、肿瘤坏死因子-α和骨桥蛋白,被鉴定为 VDRA 保护作用的潜在旁分泌因子。其中,骨桥蛋白进一步被研究,并发现其对巨噬细胞/SMC 共培养物中 VDRA 抑制钙化的作用有重要贡献。
VDRA 能够使巨噬细胞的旁分泌表型从促钙化向抗钙化转变,这可能有助于其观察到的心血管生存获益。